Rocuronium bromide: Clinical Trials

7 completed. 7 Phase 3.

By phase and status

Phase	Trials	Status
Phase 3	7	Completed 7

Follow Rocuronium bromide: new trials by email Literature Review of Rocuronium bromide trials Research Report on Rocuronium bromide

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Comparative Clinical Study of Efficacy and Safety of Remimazolam and Propofol in Patients Undergoing Elective Surgery Under General Anaesthesia Remimazolam, Propofol, Fentanyl - General Anaesthesia	Phase 3	Completed	R-Pharm	150	2017-08-22	2018-09-13
Comparison of Sugammadex With Neostigmine During Laparoscopic Cholecystectomy or Appendectomy (P05699) Rocuronium, Sugammadex, Neostigmine - Anesthesia, General	Phase 3	Completed	Merck Sharp & Dohme LLC	140	2008-07-16	2017-05-16
Comparison of Sugammadex Administered at 1-2 Post Tetanic Counts (PTCs) or Better With Neostigmine Administered as Per Standard of Care to Reverse Rocuronium-Induced Neuromuscular Blockade in Adults Undergoing Elective Open Abdominal Procedure (19.4.334) (P05774) Sugammadex, Neostigmine, Rocuronium - Anesthesia	Phase 3	Completed	Merck Sharp & Dohme LLC	100	2008-05-01	2015-03-13
Dialysis of Sugammadex in Participants With Severe Renal Impairment (Study 19.4.333) (P05773) sugammadex, Rocuronium - Neuromuscular Blockade	Phase 3	Completed	Merck Sharp & Dohme LLC	6	2008-04-01	2015-03-10
Sugammadex After Continuous Infusion of Rocuronium During Sevoflurane and Propofol Anesthesia (P05949; MK-8616-028) Sugammadex, Rocuronium, Sevoflurane - Anesthesia, General	Phase 3	Completed	Merck Sharp & Dohme LLC	52	2006-12-07	2019-11-25
Dose-Finding Pediatric and Adult Trial With Sugammadex (Org 25969, MK-8616, SCH 900616) (19.4.306) (MK-8616-034) (P05961) Sugammadex 0.5 mg/kg, Sugammadex 1 mg/kg, Sugammadex 2 mg/kg - Anesthesia	Phase 3	Completed	Merck Sharp & Dohme LLC	94	2005-05-30	2019-01-28
Study of Efficacy, Pharmacokinetics and Safety of Continuous Intravenous Infusion of Org 9426 (Study P05977) Rocuronium bromide, Sevoflurane, Propofol - Anesthesia	Phase 3	Completed	Merck Sharp & Dohme LLC	38	2003-05-01	2015-05-12

Sponsors

Merck Sharp & Dohme LLC (6)  ·  R-Pharm (1)

Countries

Russia (1)

Top investigators

Mikhail Samsonov (1)

Results publications

PMID 19194156, PMID 19512873, PMID 22698066, PMID 22732111

NIH funding

2004 (1)